# BECLOMETHASONE DIPROPIONATE
> **ANDA214418** · Abbreviated New Drug Application (Generic) · Sponsor: AUROLIFE PHARMA LLC · Approved 2026-09-14
## Drug
- **FDA Application Number:** ANDA214418
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BECLOMETHASONE DIPROPIONATE
- **Generic name:** Beclomethasone Dipropionate
- **Active ingredients:** BECLOMETHASONE DIPROPIONATE
- **Dosage form:** AEROSOL, METERED
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** AUROLIFE PHARMA LLC
- **First approval:** 2026-09-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214418)
---
*MORVS · CC0 1.0*